ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Biora Therapeutics Inc

Biora Therapeutics Inc (BIOR)

0.5678
-0.0194
(-3.30%)
Closed September 24 4:00PM
0.5775
0.0097
(1.71%)
After Hours: 7:59PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.5775
Bid
0.59
Ask
0.595
Volume
358,596
0.524 Day's Range 0.5867
0.475 52 Week Range 2.7129
Market Cap
Previous Close
0.5872
Open
0.5668
Last Trade
2
@
0.595
Last Trade Time
Financial Volume
$ 203,758
VWAP
0.568212
Average Volume (3m)
204,631
Shares Outstanding
36,469,088
Dividend Yield
-
PE Ratio
-0.17
Earnings Per Share (EPS)
-3.4
Revenue
4k
Net Profit
-124.12M

About Biora Therapeutics Inc

Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Dover, Delaware, USA
Founded
-
Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $0.59. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 0.475 to $ 2.7129.

Biora Therapeutics currently has 36,469,088 shares outstanding. The market capitalization of Biora Therapeutics is $21.41 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.17.

BIOR Latest News

Biora Therapeutics Achieves ISO 13485 Certification

SAN DIEGO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it has been awarded ISO 13485:2016...

Biora Therapeutics Announces Positive Nasdaq Listing Decision

SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that the company has been granted an...

Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0825-12.50.660.6790.54012216940.60988153CS
4-0.1125-16.30434782610.690.710.54011625980.64597672CS
12-0.0825-12.50.660.790.54012046310.66013466CS
26-0.6425-52.66393442621.221.330.4752872640.69884333CS
52-1.5525-72.88732394372.132.71290.4753720921.08905712CS
156-20.9225-97.313953488421.528.750.4759072139.90998365CS
260-20.9225-97.313953488421.528.750.4759072139.90998365CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 1.33
(129.71%)
182.46M
LASELaser Photonics Corporation
$ 18.8671
(81.24%)
13.54M
TGLTreasure Global Inc
$ 1.18
(73.45%)
139.95M
NVVENuvve Holding Corporation
$ 6.68
(70.41%)
31.34M
UXINUxin Ltd
$ 2.42
(52.68%)
18.24M
ELABElevai Labs Inc
$ 0.10545
(-62.34%)
23.66M
ADTXAditxt Inc
$ 0.262
(-31.52%)
3.17M
FRGTFreight Technologies Inc
$ 0.081
(-28.82%)
26.36M
ANEBAnebulo Pharmaceuticals Inc
$ 2.23
(-27.60%)
113.78k
STSSSharps Technology Inc
$ 0.1722
(-27.06%)
2.28M
XPONExpion360 Inc
$ 0.1144
(34.91%)
432.21M
NVDANVIDIA Corporation
$ 116.26
(0.22%)
206.23M
INTCIntel Corporation
$ 22.56
(3.30%)
184.44M
KAVLKaival Brands Innovations Group Inc
$ 1.33
(129.71%)
182.46M
TGLTreasure Global Inc
$ 1.18
(73.45%)
139.95M

BIOR Discussion

View Posts
The Night Stalker The Night Stalker 4 months ago
nice
👍️0
Arnold25764 Arnold25764 5 months ago
Any possible catalyst here?
👍️0
Monksdream Monksdream 5 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 6 months ago
BIOR new 52 lo
👍️0
Monksdream Monksdream 6 months ago
BIOR 10Q due 3/26
👍️0
Monksdream Monksdream 6 months ago
BIOR under $2
👍️0
glenn1919 glenn1919 7 months ago
BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
BIOR new 52 week low
👍️0
Monksdream Monksdream 10 months ago
BOIR new 52 week low
👍️0
Monksdream Monksdream 10 months ago
BIOR new 52 week low
👍️0
TheFinalCD TheFinalCD 10 months ago
https://finviz.com/quote.ashx?t=BIOR&p=d

https://dilutiontracker.com/app/search/BIOR
👍️0
Awl416 Awl416 10 months ago
Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
👍️0
retireat40 retireat40 11 months ago
Looked good this morning at 2.66 but a crappy close.
👍️0
Monksdream Monksdream 1 year ago
BIOR Barchart Bottom 100
Biora Therapeutics Inc NASDAQ: BIOR



GoSymbol lookup
Health Care : Biotechnology | Small Cap ValueCompany profile
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
👍️0

Your Recent History

Delayed Upgrade Clock